Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
Pharmanutra Dividend Announcement
• Pharmanutra announced a annually dividend of €0.85 per ordinary share which will be made payable on 2024-05-08. Ex dividend date: 2024-05-06
• Pharmanutra annual dividend for 2024 was €0.85
• Pharmanutra annual dividend for 2023 was €0.80
• Pharmanutra's trailing twelve-month (TTM) dividend yield is 1.55%
• Pharmanutra's payout ratio for the trailing twelve months (TTM) is 50.22%
• Pharmanutra's dividend growth over the last five years (2018-2023) was 19.38% year
Pharmanutra Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-06 | €0.85 | annually | 2024-05-08 |
2023-05-08 | €0.80 | annually | 2023-05-10 |
2022-05-02 | €0.71 | annually | 2022-05-04 |
2021-05-03 | €0.67 | annually | 2021-05-05 |
2020-05-11 | €0.46 | annually | 2020-05-13 |
2019-05-03 | €0.08 | annually | 2019-05-08 |
2018-05-07 | €0.33 | annually | 2018-05-09 |
Pharmanutra Dividend per year
Pharmanutra Dividend growth
Pharmanutra Dividend Yield
Pharmanutra current trailing twelve-month (TTM) dividend yield is 1.55%. Interested in purchasing Pharmanutra stock? Use our calculator to estimate your expected dividend yield:
Pharmanutra Financial Ratios
Pharmanutra Dividend FAQ
Other factors to consider when evaluating Pharmanutra as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Pharmanutra stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Pharmanutra's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Pharmanutra publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Pharmanutra distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Pharmanutra are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Pharmanutra sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Pharmanutra distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Pharmanutra declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Pharmanutra's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Pharmanutra's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.